131 related articles for article (PubMed ID: 8724534)
1. Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
Gartenhaus R; Hoffman M; Fuchs A; Billet H; Wang P; Gentile P; Rai K
Leuk Lymphoma; 1996 Jun; 22(1-2):97-101, follow.186, color plate IX. PubMed ID: 8724534
[TBL] [Abstract][Full Text] [Related]
2. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
[TBL] [Abstract][Full Text] [Related]
3. Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells.
Visser L; Poppema S
Br J Haematol; 1990 Jul; 75(3):359-65. PubMed ID: 2386770
[TBL] [Abstract][Full Text] [Related]
4. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
[TBL] [Abstract][Full Text] [Related]
5. Phorbol ester-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
al-Katib A; Wang CY; McKenzie S; Clarkson BD; Koziner B
Am J Hematol; 1992 Aug; 40(4):264-9. PubMed ID: 1354412
[TBL] [Abstract][Full Text] [Related]
6. CD11c (LEU-M5) expression characterizes a B-cell chronic lymphoproliferative disorder with features of both chronic lymphocytic leukemia and hairy cell leukemia.
Hanson CA; Gribbin TE; Schnitzer B; Schlegelmilch JA; Mitchell BS; Stoolman LM
Blood; 1990 Dec; 76(11):2360-7. PubMed ID: 1701669
[TBL] [Abstract][Full Text] [Related]
7. Effect of serum and antioxidants on the immunogenicity of protein kinase C-activated chronic lymphocytic leukemia cells.
Hammond C; Shi Y; Mena J; Tomic J; Cervi D; He L; Millar AE; Debenedette M; Schuh AC; Baryza JL; Wender PA; Radvanyi L; Spaner DE
J Immunother; 2005; 28(1):28-39. PubMed ID: 15614042
[TBL] [Abstract][Full Text] [Related]
8. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
Thomas A; Pepper C; Hoy T; Bentley P
Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
[TBL] [Abstract][Full Text] [Related]
10. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
11. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
Steube KG; Drexler HG
Leuk Lymphoma; 1993 Jan; 9(1-2):141-8. PubMed ID: 8477194
[TBL] [Abstract][Full Text] [Related]
12. Lineage relationship of chronic lymphocytic leukemia and hairy cell leukemia: studies with TPA.
Caligaris-Cappio F; Janossy G; Campana D; Chilosi M; Bergui L; Foà R; Delia D; Giubellino MC; Preda P; Gobbi M
Leuk Res; 1984; 8(4):567-78. PubMed ID: 6332240
[TBL] [Abstract][Full Text] [Related]
13. The effect of 12-O-tetradecanoylphorbol-13-acetate (TPA) on leukemic cells from chronic B cell leukemia.
Tokumine Y; Waki K; Nishimori Y; Kuratsune H; Inoue R; Nakamura Y; Ueda E; Machii T; Kitani T
Leukemia; 1989 Jul; 3(7):516-21. PubMed ID: 2786598
[TBL] [Abstract][Full Text] [Related]
14. Association of protein tyrosine phosphorylation with B cell differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA).
Kuratsune H; Owada MK; Tokumine Y; Tagawa S; Nojima J; Shibano M; Nishimori Y; Morita T; Machii T; Kitani T
Leukemia; 1990 Oct; 4(10):700-3. PubMed ID: 2214873
[TBL] [Abstract][Full Text] [Related]
15. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
Gazitt Y; Polliack A
Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
[TBL] [Abstract][Full Text] [Related]
16. Myelo-monocytoid immunophenotypes of B-cell chronic lymphocytic leukemia cells.
Tsuda H; Matsumi S; Nishimura H; Kawano F; Shido T; Takatsuki K
Intern Med; 1993 Jul; 32(7):533-9. PubMed ID: 8286829
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical demonstration of acid phosphatase isoenzyme 5 (tartrate-resistant) in paraffin sections of hairy cell leukemia and other hematologic disorders.
Hoyer JD; Li CY; Yam LT; Hanson CA; Kurtin PJ
Am J Clin Pathol; 1997 Sep; 108(3):308-15. PubMed ID: 9291460
[TBL] [Abstract][Full Text] [Related]
18. Immune phenotype and some enzyme patterns in phorbol ester-induced chronic lymphocytic leukemia cells.
Babusíková O; Mesárosová A; Kusenda J; Koníková E; Klobusická M; Hrivnáková A
Neoplasma; 1995; 42(5):221-6. PubMed ID: 8552199
[TBL] [Abstract][Full Text] [Related]
19. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
[TBL] [Abstract][Full Text] [Related]
20. The origin of B-chronic lymphocytic leukaemia (B-CLL) and its relationship to hairy cell leukaemia (HCL).
Caligaris-Cappio F; Bergui L; Pizzolo G; Chilosi M; Tesio L; Campana D; Semenzato G; Malavasi F; Gobbi M
Adv Exp Med Biol; 1985; 186():949-56. PubMed ID: 3931438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
